Lgi3-4 proteins modulate the KV1.5 channelosome and are potential therapeutic targets for atrial fibrillation.
Paula G Socuéllamos (Instituto de Investigaciones Biomédicas Sols-Morre/Spain), Álvaro Macías (Centro Nacional de Investigaciones Cardiovasculare/Spain), Ángela de Benito-Bueno (Instituto de Investigaciones Biomédicas Sols-Morre/Spain), Francisco M Cruz (Centro Nacional de Investigaciones Cardiovasculare/Spain), María Redondo-Moya (Instituto de Investigaciones Biomédicas Sols-Morre/Spain) 等16人
📖 Cardiovasc Res
📅 2026-03-19
I Kur
Atrial fibrillation
KV1.5 channelosome
Lgi proteins
📄 查看详情
The impact of environmental pollution and climate change on hypertension: a position paper by the European Society of Hypertension (ESH) Working Group on Environment in Hypertension.
Marek Rajzer (First Department of Cardiology/Poland), Wiktoria Wojciechowska (First Department of Cardiology/Poland), Andrzej Januszewicz (Department of Hypertension/Poland), Yu-Ling Yu (Non-Profit Research Association Alliance for the P/Belgium), Ji-Guang Wang (The Shanghai Institute of Hypertension/China) 等21人
📖 Cardiovasc Res
📅 2026-03-20
📄 查看详情
Suppressor of variegation 3-9 homolog 1 deficiency attenuates cardiac fibrosis and rescues heart failure through TACC2.
Chenghao Zhu (State Key Laboratory of Natural Medicines/China), Yujia Xue (State Key Laboratory of Natural Medicines/China), Wenxuan Hong (Department of Cardiology/China), Yuwen Zhu (Department of Laboratory Medicine/China), Xiulian Miao (Institute of Biomedical Research/China) 等9人
📖 Cardiovasc Res
📅 2026-03-20
cardiac fibroblast
cardiac fibrosis
epigenetics
myofibroblast
transcriptional regulation
📄 查看详情